Pfizer Inc. Pays $3.3 Million to Oregon Over Zyvox Marketing

Drugmaker Pfizer Inc. has agreed to pay Oregon more than $3.3 million to settle claims that the company used misleading statements and studies to market an antibiotic. The settlement announced Tuesday by Oregon Attorney General John Kroger comes after a two-year state investigation of Pfizer’s marketing of Zyvox, which is used to treat pneumonia and bacterial skin infections. Pfizer used “unreliable and unsubstantiated claims” in marketing Zyvox as a better choice than a cheaper, generic antibiotic, the state said. Pfizer’s sales representatives distributed copies of flawed clinical studies throughout Oregon to support the marketing claims, according to the state Justice Department.

MORE ON THIS TOPIC